KR20220041154A - 상처 치유를 위한 yap 억제 - Google Patents
상처 치유를 위한 yap 억제 Download PDFInfo
- Publication number
- KR20220041154A KR20220041154A KR1020227006337A KR20227006337A KR20220041154A KR 20220041154 A KR20220041154 A KR 20220041154A KR 1020227006337 A KR1020227006337 A KR 1020227006337A KR 20227006337 A KR20227006337 A KR 20227006337A KR 20220041154 A KR20220041154 A KR 20220041154A
- Authority
- KR
- South Korea
- Prior art keywords
- wound
- enf
- days
- skin
- yap
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962879369P | 2019-07-26 | 2019-07-26 | |
| US62/879,369 | 2019-07-26 | ||
| PCT/US2020/043420 WO2021021607A2 (en) | 2019-07-26 | 2020-07-24 | Yap inhibition for wound healing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20220041154A true KR20220041154A (ko) | 2022-03-31 |
Family
ID=74229013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020227006337A Ceased KR20220041154A (ko) | 2019-07-26 | 2020-07-24 | 상처 치유를 위한 yap 억제 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220313658A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4003334A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022541572A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220041154A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114401718A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020320171B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022001196A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3144185A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL289923A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021021607A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102550631B1 (ko) * | 2021-03-16 | 2023-07-03 | (주)파인헬스케어 | 인공지능을 이용한 욕창 단계 평가 및 치료 추천을 제공하는 장치 및 방법 |
| CA3220398A1 (en) * | 2021-07-30 | 2023-02-02 | Geoffrey Gurtner | Mechanotransduction disruption mediation in skin grafting methods and compositions for use in practicing the same |
| US20240366565A1 (en) * | 2021-09-09 | 2024-11-07 | The Board Of Trustees Of The Leland Stanford Junior University | Use of Verteporfin to Modulate Wound Healing After an Ocular Surgical Procedure or Ocular Injury |
| CN114288474A (zh) * | 2021-12-27 | 2022-04-08 | 湖北中部医疗科技有限公司 | 一种促毛囊再生用真皮层、人工皮肤及其制备方法 |
| EP4514393A4 (en) * | 2022-04-28 | 2026-04-01 | Univ Leland Stanford Junior | PIEZO-ELECTRIC INHIBITION FOR Wound Healing |
| CN116694089B (zh) * | 2022-09-19 | 2024-03-26 | 广州贝奥吉因生物科技股份有限公司 | 一种用于抑制瘢痕的水凝胶及其制备方法和应用 |
| CN116602265B (zh) * | 2023-05-25 | 2024-05-14 | 北京工业大学 | 一种用于建立瘢痕疙瘩动物模型的智能控制系统及方法 |
| CN117679393A (zh) * | 2023-12-04 | 2024-03-12 | 中山大学附属第一医院 | 一种负载维替泊芬治疗增生性瘢痕的生物粘性纳米缓释颗粒 |
| US20260115352A1 (en) | 2024-10-28 | 2026-04-30 | Cilag Gmbh International | Verteporfin Containing Silicone Topical Skin Adhesive for Wound Closure and Reduced Scarring |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060140984A1 (en) * | 2002-10-25 | 2006-06-29 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
| GB0823265D0 (en) * | 2008-12-20 | 2009-01-28 | Convatec Technologies Inc | Antimicrobial Composition |
| DE102010009572A1 (de) * | 2010-02-26 | 2011-09-01 | Euroderm Gmbh | Verfahren zum Begünstigen der Heilung von Hautwunden unter Verwendung der Zellen der Haarwurzelscheide, Präparat und Herstellverfahren |
| JP2014500275A (ja) * | 2010-12-06 | 2014-01-09 | フォリカ,インコーポレイテッド | 禿頭症を治療するため、および毛髪の成長を促進するための方法 |
| US9655967B2 (en) * | 2011-12-09 | 2017-05-23 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibition of focal adhesion kinase for control of scar tissue formation |
| KR101385196B1 (ko) * | 2012-05-17 | 2014-04-14 | 주식회사 유니크메디케어 | 광 조사를 이용한 광감각제―펩타이드를 유효성분으로 포함하는 발모 개선 또는 촉진용 조성물 및 이를 이용한 방법 |
| US20150157584A1 (en) * | 2012-06-11 | 2015-06-11 | The J. David Gladstone Institutes | Inhibitors of hippo-yap signaling pathway |
| EP2897689A4 (en) * | 2012-09-24 | 2016-03-30 | Cormatrix Cardiovascular Inc | COMPOSITIONS AND METHODS OF TREATING ALOPEZIA |
| IL248468A0 (en) * | 2016-10-13 | 2017-01-31 | Technion Res & Dev Foundation | Use of caspase-3 inhibitors and caspase-3 activators in the manufacture of medicament for treating cancer and wound healing |
-
2020
- 2020-07-24 CA CA3144185A patent/CA3144185A1/en active Pending
- 2020-07-24 AU AU2020320171A patent/AU2020320171B2/en active Active
- 2020-07-24 EP EP20848339.6A patent/EP4003334A4/en active Pending
- 2020-07-24 KR KR1020227006337A patent/KR20220041154A/ko not_active Ceased
- 2020-07-24 US US17/626,699 patent/US20220313658A1/en active Pending
- 2020-07-24 BR BR112022001196A patent/BR112022001196A2/pt not_active IP Right Cessation
- 2020-07-24 WO PCT/US2020/043420 patent/WO2021021607A2/en not_active Ceased
- 2020-07-24 CN CN202080063651.9A patent/CN114401718A/zh active Pending
- 2020-07-24 JP JP2022503590A patent/JP2022541572A/ja active Pending
-
2022
- 2022-01-17 IL IL289923A patent/IL289923A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020320171B2 (en) | 2025-05-29 |
| IL289923A (en) | 2022-03-01 |
| BR112022001196A2 (pt) | 2022-03-15 |
| US20220313658A1 (en) | 2022-10-06 |
| EP4003334A2 (en) | 2022-06-01 |
| CA3144185A1 (en) | 2021-02-04 |
| CN114401718A (zh) | 2022-04-26 |
| AU2020320171A1 (en) | 2022-02-17 |
| WO2021021607A3 (en) | 2021-04-08 |
| EP4003334A4 (en) | 2023-08-16 |
| WO2021021607A2 (en) | 2021-02-04 |
| JP2022541572A (ja) | 2022-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020320171B2 (en) | YAP inhibition for wound healing | |
| CN102625853B (zh) | 表皮分化微小rna标记及其应用 | |
| US20230210928A1 (en) | Screening method for laminin 511 production promoting agent, basal epidermal layer stabilizing agent, and/or epidermal stem cells reduction inhibiting or proliferation promoting agent | |
| JP6836950B2 (ja) | 細胞外マトリックスに関連した皮膚色素斑の分子シグネチャー | |
| Bellei et al. | Regenerative medicine-based treatment for vitiligo: an overview | |
| Zcharia et al. | Heparanase regulates murine hair growth | |
| JP6223960B2 (ja) | 細胞外マトリックスの組織化に関連した皮膚色素斑の分子シグネチャー | |
| Gong et al. | Protective mechanism of adipose-derived stem cells in remodelling of the skin stem cell niche during photoaging | |
| TWI614031B (zh) | 防止皮膚老化相關症狀的醫藥組合物及其使用方法 | |
| Chakraborty et al. | Stem-cell therapy in dermatology–Challenges and opportunities | |
| US20250321225A1 (en) | Skin damage organoid model and drug screening method using the same | |
| US20250195474A1 (en) | Piezo Inhibition for Wound Healing | |
| HK40071204A (en) | Yap inhibition for wound healing | |
| Bai et al. | ACE2 Inhibits Dermal Regeneration Through Ang II in Tissue Expansion | |
| Mohammed et al. | Biological skin regeneration using epigenetic targets | |
| WO2023215294A1 (en) | Complement pathway inhibition for wound healing | |
| US20230355498A1 (en) | Hair growth agent | |
| WO2024248945A2 (en) | Axl signaling pathway activator for wound healing | |
| Al Shueili | The Roles of ING5 in Regeneration and Maintaining Genomic Stability (in vivo model) | |
| US20230390356A1 (en) | Hair growth agent | |
| An | Uncovering the Cellular and Molecular Mechanisms of UVB-Induced Melanocyte Stem Cell Activation and Epidermal Migration | |
| Nicu et al. | 922 Dermal white adipose tissue secretes hepatocyte growth factor to promote human hair follicle growth and pigmentation | |
| Syu et al. | 920 The non-coding control region of Trichodysplasia spinulosa polyomavirus is responsible for cell-type specific viral gene expression in vivo | |
| Hopkins et al. | 919 Overexpression of cyclooxygenase-2 in the skin of adult transgenic mice leads to sebaceous gland hyperplasia and thinning of hair shafts | |
| Sallee et al. | 923 Molecular phenotyping of lichen planopilaris revealed dysregulation of cholesterol/fatty acid metabolism, fibrosis and mast cell pathways |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| D21 | Rejection of application intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| E13 | Pre-grant limitation requested |
Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| B15 | Application refused following examination |
Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B15-EXM-PE0601 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0601 | Decision on rejection of patent |
St.27 status event code: N-2-6-B10-B15-exm-PE0601 |